Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT-114143 for reducing perioperative blood loss in unilateral total knee arthroplasty
CTR20252665Phase 2Active
- Sponsor
- SinoHub Pharmaceutical
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BT-114143 in perioperative bleeding, sponsored by SinoHub Pharmaceutical. Started Sep 2025; status: active.
02
Drugs
BT-114143
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on CTR20252665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252665.